Teladoc Health Inc. [NYSE: TDOC] traded at a low on 03/25/21, posting a -3.20 loss after which it closed the day’ session at $176.16. The company report on February 25, 2021 that HealthTech Trends 2021: CEO’s of Teladoc, Reliq Health, Relay Medical and Veeva Systems, Driving Revenue Growth with Innovation and New Markets Expansions.
Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Teladoc Health (NYSE: TDOC), Reliq Health Technologies (OTC:RQHTF) (TSX.V:RHT), Relay Medical (CSE: RELA) (OTC: RYMDF) and Veeva Systems (NYSE: VEEV).
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
The US healthcare market is estimated at $2.8 trillion – and the largest in the world. Fast moving innovators are now driving a transformation wave – and creating new opportunities for investors. Wall Street Reporter highlights the latest comments from industry thought leaders:.
The results of the trading session contributed to over 6399029 shares changing hands. Over the past one week, the price volatility of Teladoc Health Inc. stands at 5.26% while the volatility over the past one month is 6.90%.
The market cap for TDOC stock reached $26.12 billion, with 152.70 million shares outstanding and 150.92 million shares in the current float. Compared to the average trading volume of 3.65M shares, TDOC reached a trading volume of 6399029 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Teladoc Health Inc. [TDOC]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TDOC shares is $259.81 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TDOC stock is a recommendation set at 2.10. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BTIG Research have made an estimate for Teladoc Health Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 07, 2021. While these analysts kept the previous recommendation, Evercore ISI raised their target price to In-line. The new note on the price target was released on December 22, 2020, representing the official price target for Teladoc Health Inc. stock. Previously, the target price had yet another drop from $270 to $210, while Stephens kept a Equal-Weight rating on TDOC stock.
The Average True Range (ATR) for Teladoc Health Inc. is set at 14.42, with the Price to Sales ratio for TDOC stock in the period of the last 12 months amounting to 23.87. The Price to Book ratio for the last quarter was 1.43, with the Price to Cash per share for the same quarter was set at 5.30.
How has TDOC stock performed recently?
Teladoc Health Inc. [TDOC] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -5.00. With this latest performance, TDOC shares dropped by -30.79% in over the last four-week period, additionally sinking by -15.80% over the last 6 months – not to mention a rise of 23.96% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TDOC stock in for the last two-week period is set at 33.35, with the RSI for the last a single of trading hit 30.85, and the three-weeks RSI is set at 36.12 for Teladoc Health Inc. [TDOC]. The present Moving Average for the last 50 days of trading for this stock 238.62, while it was recorded at 188.03 for the last single week of trading, and 214.34 for the last 200 days.
Teladoc Health Inc. [TDOC]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Teladoc Health Inc. [TDOC] shares currently have an operating margin of -37.42 and a Gross Margin at +57.92. Teladoc Health Inc.’s Net Margin is presently recorded at -44.35.
Return on Total Capital for TDOC is now -4.34, given the latest momentum, and Return on Invested Capital for the company is -5.16. Return on Equity for this stock declined to -5.74, with Return on Assets sitting at -4.86. When it comes to the capital structure of this company, Teladoc Health Inc. [TDOC] has a Total Debt to Total Equity ratio set at 9.30. Additionally, TDOC Total Debt to Total Capital is recorded at 8.51, with Total Debt to Total Assets ending up at 8.07. Long-Term Debt to Equity for the company is recorded at 8.96, with the Long-Term Debt to Total Capital now at 8.20.
Reflecting on the efficiency of the workforce at the company, Teladoc Health Inc. [TDOC] managed to generate an average of -$110,258 per employee. Receivables Turnover for the company is 9.67 with a Total Asset Turnover recorded at a value of 0.11.Teladoc Health Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.00 and a Current Ratio set at 3.20.
Earnings analysis for Teladoc Health Inc. [TDOC]
With the latest financial reports released by the company, Teladoc Health Inc. posted -0.4/share EPS, while the average EPS was predicted by analysts to be reported at -0.36/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -11.10%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TDOC. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Teladoc Health Inc. go to -0.92%.
Insider trade positions for Teladoc Health Inc. [TDOC]
There are presently around $20,665 million, or 77.30% of TDOC stock, in the hands of institutional investors. The top three institutional holders of TDOC stocks are: VANGUARD GROUP INC with ownership of 11,473,659, which is approximately 11.23% of the company’s market cap and around 0.80% of the total institutional ownership; BLACKROCK INC., holding 9,312,347 shares of the stock with an approximate value of $1.64 billion in TDOC stocks shares; and GENERAL CATALYST GROUP MANAGEMENT, LLC, currently with $1.42 billion in TDOC stock with ownership of nearly New of the company’s market capitalization.
Positions in Teladoc Health Inc. stocks held by institutional investors increased at the end of February and at the time of the February reporting period, where 564 institutional holders increased their position in Teladoc Health Inc. [NYSE:TDOC] by around 30,704,844 shares. Additionally, 406 investors decreased positions by around 17,461,240 shares, while 74 investors held positions by with 69,142,955 shares. The mentioned changes placed institutional holdings at 117,309,039 shares, according to the latest SEC report filing. TDOC stock had 178 new institutional investments in for a total of 9,410,773 shares, while 158 institutional investors sold positions of 8,875,733 shares during the same period.